annual operating profit:
$4.39B+$87.50M(+2.03%)Summary
- As of today (April 25, 2025), VRTX annual operating income is $4.39 billion, with the most recent change of +$87.50 million (+2.03%) on December 31, 2024.
- During the last 3 years, VRTX annual operating profit has risen by +$1.62 billion (+58.15%).
- VRTX annual operating profit is now at all-time high.
Performance
VRTX Operating profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly operating profit:
$1.11B-$19.30M(-1.71%)Summary
- As of today (April 25, 2025), VRTX quarterly operating income is $1.11 billion, with the most recent change of -$19.30 million (-1.71%) on December 31, 2024.
- Over the past year, VRTX quarterly operating profit has increased by +$156.30 million (+16.35%).
- VRTX quarterly operating profit is now -8.54% below its all-time high of $1.22 billion, reached on March 31, 2024.
Performance
VRTX quarterly operating profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM operating profit:
$4.39B+$156.30M(+3.69%)Summary
- As of today (April 25, 2025), VRTX TTM operating income is $4.39 billion, with the most recent change of +$156.30 million (+3.69%) on December 31, 2024.
- Over the past year, VRTX TTM operating profit has increased by +$87.50 million (+2.03%).
- VRTX TTM operating profit is now -1.71% below its all-time high of $4.47 billion, reached on June 30, 2023.
Performance
VRTX TTM operating profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Operating profit Formula
Operating Profit = Gross Profit − Operating Expenses
VRTX Operating profit Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +2.0% | +16.4% | +2.0% |
| 3 y3 years | +58.1% | -3.5% | +5.1% |
| 5 y5 years | +265.6% | -3.5% | +5.1% |
VRTX Operating profit Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +58.1% | -8.5% | +19.0% | -1.7% | +50.0% |
| 5 y | 5-year | at high | +265.6% | -8.5% | +3164.2% | -1.7% | +166.8% |
| alltime | all time | at high | +732.8% | -8.5% | +630.0% | -1.7% | +732.8% |
Vertex Pharmaceuticals Incorporated Operating profit History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2024 | $4.39B(+2.0%) | $1.11B(-1.7%) | $4.39B(+3.7%) |
| Sep 2024 | - | $1.13B(+21.0%) | $4.24B(+1.0%) |
| Jun 2024 | - | $934.90M(-23.1%) | $4.20B(-4.6%) |
| Mar 2024 | - | $1.22B(+27.2%) | $4.40B(+2.1%) |
| Dec 2023 | $4.31B(-1.3%) | $956.00M(-12.4%) | $4.31B(-2.3%) |
| Sep 2023 | - | $1.09B(-4.0%) | $4.41B(-1.4%) |
| Jun 2023 | - | $1.14B(+1.1%) | $4.47B(+0.4%) |
| Mar 2023 | - | $1.12B(+6.3%) | $4.45B(+2.0%) |
| Dec 2022 | $4.37B(+57.1%) | $1.06B(-8.3%) | $4.37B(+4.4%) |
| Sep 2022 | - | $1.15B(+3.0%) | $4.18B(+2.4%) |
| Jun 2022 | - | $1.12B(+8.1%) | $4.09B(+39.4%) |
| Mar 2022 | - | $1.04B(+18.2%) | $2.93B(+5.5%) |
| Dec 2021 | $2.78B(-3.2%) | $875.70M(-17.1%) | $2.78B(+4.9%) |
| Sep 2021 | - | $1.06B(-3008.3%) | $2.65B(+16.8%) |
| Jun 2021 | - | -$36.30M(-104.1%) | $2.27B(-25.2%) |
| Mar 2021 | - | $883.90M(+18.4%) | $3.03B(+5.6%) |
| Dec 2020 | $2.87B(+138.7%) | $746.30M(+10.7%) | $2.87B(+7.2%) |
| Sep 2020 | - | $674.04M(-7.3%) | $2.68B(+27.2%) |
| Jun 2020 | - | $727.23M(+0.7%) | $2.10B(+27.8%) |
| Mar 2020 | - | $721.82M(+30.5%) | $1.65B(+37.0%) |
| Dec 2019 | $1.20B(+81.0%) | $552.94M(+440.6%) | $1.20B(+49.2%) |
| Sep 2019 | - | $102.29M(-62.1%) | $805.79M(-11.4%) |
| Jun 2019 | - | $269.96M(-2.5%) | $908.97M(+11.9%) |
| Mar 2019 | - | $276.81M(+76.6%) | $811.95M(+22.3%) |
| Dec 2018 | $663.97M(+69.0%) | $156.73M(-23.7%) | $663.97M(+4.8%) |
| Sep 2018 | - | $205.47M(+18.8%) | $633.36M(+77.2%) |
| Jun 2018 | - | $172.94M(+34.2%) | $357.52M(+48.5%) |
| Mar 2018 | - | $128.82M(+2.1%) | $240.81M(-38.7%) |
| Dec 2017 | $392.83M(+3408.0%) | $126.12M(-279.2%) | $392.83M(+28.1%) |
| Sep 2017 | - | -$70.37M(-225.1%) | $306.57M(-14.4%) |
| Jun 2017 | - | $56.23M(-80.0%) | $358.22M(+17.2%) |
| Mar 2017 | - | $280.84M(+604.5%) | $305.68M(+2629.8%) |
| Dec 2016 | $11.20M(-102.4%) | $39.86M(-313.0%) | $11.20M(-113.9%) |
| Sep 2016 | - | -$18.72M(-606.5%) | -$80.85M(-38.0%) |
| Jun 2016 | - | $3.70M(-127.1%) | -$130.33M(-57.0%) |
| Mar 2016 | - | -$13.64M(-73.9%) | -$303.06M(-34.8%) |
| Dec 2015 | -$464.67M(-27.6%) | -$52.18M(-23.5%) | -$464.67M(-17.3%) |
| Sep 2015 | - | -$68.20M(-59.7%) | -$561.95M(-5.6%) |
| Jun 2015 | - | -$169.04M(-3.5%) | -$595.11M(-1.9%) |
| Mar 2015 | - | -$175.26M(+17.3%) | -$606.89M(-5.4%) |
| Dec 2014 | -$641.49M(+309.7%) | -$149.46M(+47.5%) | -$641.49M(+35.1%) |
| Sep 2014 | - | -$101.36M(-43.9%) | -$474.65M(-2.1%) |
| Jun 2014 | - | -$180.81M(-13.8%) | -$484.80M(+34.6%) |
| Mar 2014 | - | -$209.85M(-1307.7%) | -$360.14M(+105.0%) |
| Dec 2013 | -$156.59M(-422.4%) | $17.38M(-115.6%) | -$175.64M(-22.3%) |
| Sep 2013 | - | -$111.51M(+98.6%) | -$225.90M(+96.8%) |
| Jun 2013 | - | -$56.16M(+121.5%) | -$114.77M(+66.8%) |
| Mar 2013 | - | -$25.35M(-22.9%) | -$68.79M(-241.6%) |
| Dec 2012 | $48.57M(-78.1%) | -$32.89M(+8669.9%) | $48.57M(-84.1%) |
| Sep 2012 | - | -$375.00K(-96.3%) | $306.35M(-51.2%) |
| Jun 2012 | - | -$10.18M(-111.1%) | $627.82M(+32.8%) |
| Mar 2012 | - | $92.01M(-59.1%) | $472.84M(+113.3%) |
| Dec 2011 | $221.69M(-131.9%) | $224.89M(-30.0%) | $221.69M(-228.8%) |
| Sep 2011 | - | $321.09M(-294.4%) | -$172.09M(-75.1%) |
| Jun 2011 | - | -$165.15M(+3.8%) | -$691.90M(-0.3%) |
| Mar 2011 | - | -$159.14M(-5.8%) | -$694.21M(-0.1%) |
| Dec 2010 | -$694.58M(+17.2%) | -$168.89M(-15.0%) | -$694.58M(+4.7%) |
| Sep 2010 | - | -$198.72M(+18.7%) | -$663.25M(+8.4%) |
| Jun 2010 | - | -$167.46M(+5.0%) | -$611.98M(+1.9%) |
| Mar 2010 | - | -$159.50M(+15.9%) | -$600.58M(+1.3%) |
| Dec 2009 | -$592.78M(+29.3%) | -$137.56M(-6.7%) | -$592.78M(-0.4%) |
| Sep 2009 | - | -$147.46M(-5.5%) | -$595.44M(+3.1%) |
| Jun 2009 | - | -$156.06M(+2.9%) | -$577.72M(+12.8%) |
| Mar 2009 | - | -$151.70M(+8.2%) | -$511.98M(+11.7%) |
| Dec 2008 | -$458.38M(+11.1%) | -$140.22M(+8.1%) | -$458.38M(+11.9%) |
| Sep 2008 | - | -$129.74M(+43.7%) | -$409.63M(+4.3%) |
| Jun 2008 | - | -$90.31M(-7.9%) | -$392.80M(-8.1%) |
| Mar 2008 | - | -$98.11M(+7.3%) | -$427.20M(+3.5%) |
| Dec 2007 | -$412.67M | -$91.47M(-19.0%) | -$412.67M(+16.2%) |
| Sep 2007 | - | -$112.91M(-9.5%) | -$355.11M(+17.2%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2007 | - | -$124.71M(+49.2%) | -$302.91M(+17.9%) |
| Mar 2007 | - | -$83.57M(+146.5%) | -$256.97M(+14.0%) |
| Dec 2006 | -$225.39M(+59.0%) | -$33.91M(-44.2%) | -$225.39M(+6.6%) |
| Sep 2006 | - | -$60.71M(-22.9%) | -$211.48M(+10.3%) |
| Jun 2006 | - | -$78.78M(+51.5%) | -$191.68M(+25.1%) |
| Mar 2006 | - | -$51.99M(+160.0%) | -$153.24M(+8.1%) |
| Dec 2005 | -$141.74M(+3.3%) | -$20.00M(-51.1%) | -$141.74M(-5.4%) |
| Sep 2005 | - | -$40.92M(+1.4%) | -$149.82M(+4.8%) |
| Jun 2005 | - | -$40.34M(-0.4%) | -$142.93M(-0.0%) |
| Mar 2005 | - | -$40.49M(+44.2%) | -$142.99M(+4.2%) |
| Dec 2004 | -$137.23M(-20.5%) | -$28.08M(-17.5%) | -$137.23M(-7.0%) |
| Sep 2004 | - | -$34.03M(-15.8%) | -$147.56M(-6.4%) |
| Jun 2004 | - | -$40.40M(+16.3%) | -$157.57M(-23.6%) |
| Mar 2004 | - | -$34.73M(-9.6%) | -$206.18M(+35.4%) |
| Dec 2003 | -$172.70M(+16.7%) | -$38.41M(-12.8%) | -$152.24M(-13.4%) |
| Sep 2003 | - | -$44.04M(-50.5%) | -$175.86M(+4.9%) |
| Jun 2003 | - | -$89.01M(-563.4%) | -$167.67M(+63.3%) |
| Mar 2003 | - | $19.21M(-131.0%) | -$102.69M(-30.6%) |
| Dec 2002 | -$147.96M(+28.5%) | -$62.02M(+73.0%) | -$147.96M(+1.3%) |
| Sep 2002 | - | -$35.85M(+49.2%) | -$146.06M(+11.8%) |
| Jun 2002 | - | -$24.03M(-7.8%) | -$130.61M(+5.3%) |
| Mar 2002 | - | -$26.06M(-56.6%) | -$124.03M(+9.4%) |
| Dec 2001 | -$115.10M(+207.4%) | -$60.12M(+194.7%) | -$113.36M(+70.7%) |
| Sep 2001 | - | -$20.40M(+16.9%) | -$66.41M(+8.5%) |
| Jun 2001 | - | -$17.45M(+13.3%) | -$61.18M(+78.5%) |
| Mar 2001 | - | -$15.39M(+17.0%) | -$34.28M(-6.9%) |
| Dec 2000 | -$37.44M(-26.0%) | -$13.16M(-13.2%) | -$36.80M(+51.8%) |
| Sep 2000 | - | -$15.17M(-260.5%) | -$24.25M(-4.4%) |
| Jun 2000 | - | $9.45M(-152.7%) | -$25.37M(-47.1%) |
| Mar 2000 | - | -$17.92M(+2867.1%) | -$48.00M(-4.9%) |
| Dec 1999 | -$50.60M(+5.9%) | -$604.00K(-96.3%) | -$50.48M(-34.9%) |
| Sep 1999 | - | -$16.30M(+23.7%) | -$77.58M(+22.4%) |
| Jun 1999 | - | -$13.18M(-35.4%) | -$63.38M(+6.0%) |
| Mar 1999 | - | -$20.40M(-26.4%) | -$59.80M(+15.7%) |
| Dec 1998 | -$47.80M(+149.0%) | -$27.70M(+1219.0%) | -$51.70M(+69.5%) |
| Sep 1998 | - | -$2.10M(-78.1%) | -$30.50M(-10.6%) |
| Jun 1998 | - | -$9.60M(-22.0%) | -$34.10M(+32.7%) |
| Mar 1998 | - | -$12.30M(+89.2%) | -$25.70M(+35.3%) |
| Dec 1997 | -$19.20M(-51.4%) | -$6.50M(+14.0%) | -$19.00M(-31.4%) |
| Sep 1997 | - | -$5.70M(+375.0%) | -$27.70M(-5.8%) |
| Jun 1997 | - | -$1.20M(-78.6%) | -$29.40M(-19.5%) |
| Mar 1997 | - | -$5.60M(-63.2%) | -$36.50M(-7.6%) |
| Dec 1996 | -$39.50M(+49.1%) | -$15.20M(+105.4%) | -$39.50M(+48.5%) |
| Sep 1996 | - | -$7.40M(-10.8%) | -$26.60M(-2.2%) |
| Jun 1996 | - | -$8.30M(-3.5%) | -$27.20M(-6.8%) |
| Mar 1996 | - | -$8.60M(+273.9%) | -$29.20M(+10.2%) |
| Dec 1995 | -$26.50M(+28.0%) | -$2.30M(-71.3%) | -$26.50M(-18.7%) |
| Sep 1995 | - | -$8.00M(-22.3%) | -$32.60M(+14.8%) |
| Jun 1995 | - | -$10.30M(+74.6%) | -$28.40M(+20.9%) |
| Mar 1995 | - | -$5.90M(-29.8%) | -$23.50M(+13.0%) |
| Dec 1994 | -$20.70M(-1825.0%) | -$8.40M(+121.1%) | -$20.80M(+447.4%) |
| Sep 1994 | - | -$3.80M(-29.6%) | -$3.80M(+31.0%) |
| Jun 1994 | - | -$5.40M(+68.8%) | -$2.90M(-293.3%) |
| Mar 1994 | - | -$3.20M(-137.2%) | $1.50M(+25.0%) |
| Dec 1993 | $1.20M(-112.0%) | $8.60M(-396.6%) | $1.20M(-111.7%) |
| Sep 1993 | - | -$2.90M(+190.0%) | -$10.30M(+3.0%) |
| Jun 1993 | - | -$1.00M(-71.4%) | -$10.00M(-11.5%) |
| Mar 1993 | - | -$3.50M(+20.7%) | -$11.30M(+14.1%) |
| Dec 1992 | -$10.00M(+78.6%) | -$2.90M(+11.5%) | -$9.90M(+13.8%) |
| Sep 1992 | - | -$2.60M(+13.0%) | -$8.70M(+16.0%) |
| Jun 1992 | - | -$2.30M(+9.5%) | -$7.50M(+15.4%) |
| Mar 1992 | - | -$2.10M(+23.5%) | -$6.50M(+80.6%) |
| Dec 1991 | -$5.60M(+36.6%) | -$1.70M(+21.4%) | -$3.60M(-53.2%) |
| Sep 1991 | - | -$1.40M(+7.7%) | -$7.70M(+35.1%) |
| Jun 1991 | - | -$1.30M(-262.5%) | -$5.70M(+50.0%) |
| Mar 1991 | - | $800.00K(-113.8%) | -$3.80M(-7.3%) |
| Dec 1990 | -$4.10M | -$5.80M(-1066.7%) | -$4.10M(-341.2%) |
| Sep 1990 | - | $600.00K(0.0%) | $1.70M(+54.5%) |
| Jun 1990 | - | $600.00K(+20.0%) | $1.10M(+120.0%) |
| Mar 1990 | - | $500.00K | $500.00K |
FAQ
- What is Vertex Pharmaceuticals Incorporated annual operating income?
- What is the all time high annual operating profit for Vertex Pharmaceuticals Incorporated?
- What is Vertex Pharmaceuticals Incorporated annual operating profit year-on-year change?
- What is Vertex Pharmaceuticals Incorporated quarterly operating income?
- What is the all time high quarterly operating profit for Vertex Pharmaceuticals Incorporated?
- What is Vertex Pharmaceuticals Incorporated quarterly operating profit year-on-year change?
- What is Vertex Pharmaceuticals Incorporated TTM operating income?
- What is the all time high TTM operating profit for Vertex Pharmaceuticals Incorporated?
- What is Vertex Pharmaceuticals Incorporated TTM operating profit year-on-year change?
What is Vertex Pharmaceuticals Incorporated annual operating income?
The current annual operating profit of VRTX is $4.39B
What is the all time high annual operating profit for Vertex Pharmaceuticals Incorporated?
Vertex Pharmaceuticals Incorporated all-time high annual operating income is $4.39B
What is Vertex Pharmaceuticals Incorporated annual operating profit year-on-year change?
Over the past year, VRTX annual operating income has changed by +$87.50M (+2.03%)
What is Vertex Pharmaceuticals Incorporated quarterly operating income?
The current quarterly operating profit of VRTX is $1.11B
What is the all time high quarterly operating profit for Vertex Pharmaceuticals Incorporated?
Vertex Pharmaceuticals Incorporated all-time high quarterly operating income is $1.22B
What is Vertex Pharmaceuticals Incorporated quarterly operating profit year-on-year change?
Over the past year, VRTX quarterly operating income has changed by +$156.30M (+16.35%)
What is Vertex Pharmaceuticals Incorporated TTM operating income?
The current TTM operating profit of VRTX is $4.39B
What is the all time high TTM operating profit for Vertex Pharmaceuticals Incorporated?
Vertex Pharmaceuticals Incorporated all-time high TTM operating income is $4.47B
What is Vertex Pharmaceuticals Incorporated TTM operating profit year-on-year change?
Over the past year, VRTX TTM operating income has changed by +$87.50M (+2.03%)